Pathogenesis
Pathogenesis of intrahepatic cholestasis of pregnancy is unclear
- multiple factors probably interact with a genetic predisposition to alter the membrane composition of bile ducts and hepatocytes and increase their sensitivity to sex steroids
- a family history (autosomal dominant and possibly X linked) is commonly associated with haplotypes HLA-B8 and HLA-Bw16
- hormonal factors are implicated because intrahepatic cholestasis worsens with multiple pregnancies and can recur with menstruation and oestrogen treatment
- occurs more commonly in mothers of patients with rare, inborn cholestatic syndromes such as progressive familial intrahepatic cholestasis type 3 or recurrent familial intrahepatic cholestasis, both related to dysfunction of biliary transporters
Reference:
- Walker KF et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD000493. DOI: 10.1002/14651858.CD000493.pub3.
- Royal College of Obstetricians and Gynaecologists. Intrahepatic cholestasis of pregnancy (Green-top Guideline No. 43). Published August 2022
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page